Novel avenues of tau research.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Volume: 20

Issue: 3

Year of Publication: 2024

Affiliated Institutions:  Alzheimer's Association, Chicago, Illinois, USA. Department of Neurology, David Geffen School of Medicine, Brain Research Institute, Molecular Biology Institute, University of California Los Angeles (UCLA), Los Angeles, California, USA. UK Dementia Research Institute at the University of Edinburgh, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK. Eli Lilly & Co., Indianapolis, Indiana, USA. Univ Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, LabEx DISTALZ, Place de Verdun, Lille, France. Sussex Neuroscience, School of Life Sciences, University of Sussex, Falmer, UK. Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA. University of Pittsburgh, School of Medicine, Department of Psychiatry and Alzheimer's disease Research Center, Pittsburgh, Pennsylvania, USA. Departments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA. CurePSP, Inc, New York, New York, USA. Sam & Ann Barshop Institute for Longevity & Aging Studies Glenn Biggs Institute for Alzheimer's & Neurodegenerative Disorders Department of Cell Systems and Anatomy University of Texas Health San Antonio, San Antonio, Texas, USA. Helen and Robert Appel Alzheimer Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA. Department of Genetics & Genomic Sciences, Ronald M. Loeb Center for Alzheimer's disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA. Janssen R&D, Neuroscience, San Diego, California, USA. Aging Institute, Neuroscience Program, Psychiatry Department, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia. Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, Baltimore, Maryland, USA. Departments of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, California, USA. Department of Neurodegenerative Disease, Dementia Research Centre, University College London Institute of Neurology, Queen Square, London, UK. Rainwater Charitable Foundation, Fort Worth, Texas, USA. Sean M. Healey &AMG Center for ALS at Mass General, Massachusetts General Hospital, Boston, Massachusetts, USA. Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. Rush Alzheimer's Disease Center, Chicago, Illinois, USA. Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Neurochemistry Laboratory, Clinical Chemistry department, Amsterdam Neuroscience, Program Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. FBRI, Cambridge, Massachusetts, USA. Independent Science Writer, Bryn Mawr, Pennsylvania, USA. Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA.

Abstract summary 

The pace of innovation has accelerated in virtually every area of tau research in just the past few years.In February 2022, leading international tau experts convened to share selected highlights of this work during Tau 2022, the second international tau conference co-organized and co-sponsored by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation.Representing academia, industry, and the philanthropic sector, presenters joined more than 1700 registered attendees from 59 countries, spanning six continents, to share recent advances and exciting new directions in tau research.The virtual meeting provided an opportunity to foster cross-sector collaboration and partnerships as well as a forum for updating colleagues on research-advancing tools and programs that are steadily moving the field forward.

Authors & Co-authors:  Sexton Claire E CE Bitan Gal G Bowles Kathryn R KR Brys Miroslaw M Buée Luc L Maina Mahmoud Bukar MB Clelland Claire D CD Cohen Ann D AD Crary John F JF Dage Jeffrey L JL Diaz Kristophe K Frost Bess B Gan Li L Goate Alison M AM Golbe Lawrence I LI Hansson Oskar O Karch Celeste M CM Kolb Hartmuth C HC La Joie Renaud R Lee Suzee E SE Matallana Diana D Miller Bruce L BL Onyike Chiadi U CU Quiroz Yakeel T YT Rexach Jessica E JE Rohrer Jonathan D JD Rommel Amy A Sadri-Vakili Ghazaleh G Schindler Suzanne E SE Schneider Julie A JA Sperling Reisa A RA Teunissen Charlotte E CE Weninger Stacie C SC Worley Susan L SL Zheng Hui H Carrillo Maria C MC

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Sexton C, Snyder H, Beher D, et al. Current directions in tau research: highlights from Tau 2020. Alzheimers Dement. 2022;18:988‐1007. doi:10.1002/alz.12452
Authors :  36
Identifiers
Doi : 10.1002/alz.13533
SSN : 1552-5279
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
biomarkers;tau;tau-PET;tauopathies;therapeutics
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
United States